Q-TWiST analysis comparing ipilimumab/dacarbazine vs placebo/dacarbazine for patients with stage III/IV melanoma

BACKGROUND: Study CA184024 was a multinational, randomised, double-blind, phase 3 study comparing ipilimumab/dacarbazine (DTIC) vs placebo/DTIC in patients with untreated stage III/IV melanoma, which showed that ipilimumab significantly improves survival in patients with metastatic melanoma. The obj...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sherrill, B, Wang, J, Kotapati, S, Chin, K
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3708560/
https://ncbi.nlm.nih.gov/pubmed/23787916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.298
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados